TRVI Covered Call Strategy
TRVI (Trevi Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.
TRVI (Trevi Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $2.17B, a beta of 1.08 versus the broader market, a 52-week range of 5.38-16.12, average daily share volume of 1.5M, a public-listing history dating back to 2019, approximately 31 full-time employees. These structural characteristics shape how TRVI stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.08 places TRVI roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a covered call on TRVI?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current TRVI snapshot
As of May 15, 2026, spot at $14.21, ATM IV 63.30%, IV rank 7.27%, expected move 18.15%. The covered call on TRVI below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.
Why this covered call structure on TRVI specifically: TRVI IV at 63.30% is on the cheap side of its 1-year range, which means a premium-selling TRVI covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 18.15% (roughly $2.58 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated TRVI expiries trade a higher absolute premium for lower per-day decay. Position sizing on TRVI should anchor to the underlying notional of $14.21 per share and to the trader's directional view on TRVI stock.
TRVI covered call setup
The TRVI covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With TRVI near $14.21, the first option leg uses a $15.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed TRVI chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 TRVI shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $14.21 | long |
| Sell 1 | Call | $15.00 | $0.98 |
TRVI covered call risk and reward
- Net Premium / Debit
- -$1,323.50
- Max Profit (per contract)
- $176.50
- Max Loss (per contract)
- -$1,322.50
- Breakeven(s)
- $13.24
- Risk / Reward Ratio
- 0.133
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
TRVI covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on TRVI. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -99.9% | -$1,322.50 |
| $3.15 | -77.8% | -$1,008.42 |
| $6.29 | -55.7% | -$694.34 |
| $9.43 | -33.6% | -$380.26 |
| $12.57 | -11.5% | -$66.18 |
| $15.71 | +10.6% | +$176.50 |
| $18.85 | +32.7% | +$176.50 |
| $22.00 | +54.8% | +$176.50 |
| $25.14 | +76.9% | +$176.50 |
| $28.28 | +99.0% | +$176.50 |
When traders use covered call on TRVI
Covered calls on TRVI are an income strategy run on existing TRVI stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
TRVI thesis for this covered call
The market-implied 1-standard-deviation range for TRVI extends from approximately $11.63 on the downside to $16.79 on the upside. A TRVI covered call collects premium on an existing long TRVI position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether TRVI will breach that level within the expiration window. Current TRVI IV rank near 7.27% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on TRVI at 63.30%. As a Healthcare name, TRVI options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to TRVI-specific events.
TRVI covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. TRVI positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move TRVI alongside the broader basket even when TRVI-specific fundamentals are unchanged. Short-premium structures like a covered call on TRVI carry tail risk when realized volatility exceeds the implied move; review historical TRVI earnings reactions and macro stress periods before sizing. Always rebuild the position from current TRVI chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on TRVI?
- A covered call on TRVI is the covered call strategy applied to TRVI (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With TRVI stock trading near $14.21, the strikes shown on this page are snapped to the nearest listed TRVI chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are TRVI covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the TRVI covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 63.30%), the computed maximum profit is $176.50 per contract and the computed maximum loss is -$1,322.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a TRVI covered call?
- The breakeven for the TRVI covered call priced on this page is roughly $13.24 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current TRVI market-implied 1-standard-deviation expected move is approximately 18.15%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on TRVI?
- Covered calls on TRVI are an income strategy run on existing TRVI stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current TRVI implied volatility affect this covered call?
- TRVI ATM IV is at 63.30% with IV rank near 7.27%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.